Literature DB >> 31278863

Hypometabolic gliomas on FET-PET-is there an inverted U-curve for survival?

David Olayinka Kamson1,2.   

Abstract

Entities:  

Keywords:  FET; U-curve; glioma; hypometabolic; photopenic

Mesh：

Substances：

Year:  2019        PMID： 31278863      PMCID： PMC6784274          DOI： 10.1093/neuonc/noz122

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  9 in total

1.  MRI-suspected low-grade glioma: is there a need to perform dynamic FET PET?

Authors:  Nathalie L Jansen; Vera Graute; Lena Armbruster; Bogdana Suchorska; Juergen Lutz; Sabina Eigenbrod; Paul Cumming; Peter Bartenstein; Jörg-Christian Tonn; Friedrich Wilhelm Kreth; Christian la Fougère
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-04-11       Impact factor: 9.236

Review 2.  Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.

Authors:  Nathalie L Albert; Michael Weller; Bogdana Suchorska; Norbert Galldiks; Riccardo Soffietti; Michelle M Kim; Christian la Fougère; Whitney Pope; Ian Law; Javier Arbizu; Marc C Chamberlain; Michael Vogelbaum; Ben M Ellingson; Joerg C Tonn
Journal:  Neuro Oncol       Date:  2016-04-21       Impact factor: 12.300

3.  Prognostic Value of O-(2-[18F]Fluoroethyl)-L-Tyrosine PET/CT in Newly Diagnosed WHO 2016 Grade II and III Glioma.

Authors:  Olivia Kertels; Almuth F Kessler; Milena I Mihovilovic; Antje Stolzenburg; Thomas Linsenmann; Samuel Samnick; Stephanie Brändlein; Camelia Maria Monoranu; Ralf-Ingo Ernestus; Andreas K Buck; Mario Löhr; Constantin Lapa
Journal:  Mol Imaging Biol       Date:  2019-12       Impact factor: 3.488

4.  Prognostic value of O-(2-18F-fluoroethyl)-L-tyrosine PET and MRI in low-grade glioma.

Authors:  Frank W Floeth; Dirk Pauleit; Michael Sabel; Gabriele Stoffels; Guido Reifenberger; Markus J Riemenschneider; Paul Jansen; Heinz H Coenen; Hans-Jakob Steiger; Karl-Josef Langen
Journal:  J Nucl Med       Date:  2007-04       Impact factor: 10.057

5.  Role of O-(2-18F-fluoroethyl)-L-tyrosine PET as a diagnostic tool for detection of malignant progression in patients with low-grade glioma.

Authors:  Norbert Galldiks; Gabriele Stoffels; Maximilian I Ruge; Marion Rapp; Michael Sabel; Guido Reifenberger; Zuhal Erdem; Nadim J Shah; Gereon R Fink; Heinz H Coenen; Karl-Josef Langen
Journal:  J Nucl Med       Date:  2013-10-24       Impact factor: 10.057

6.  Photopenic defects on O-(2-[18F]-fluoroethyl)-L-tyrosine PET: clinical relevance in glioma patients.

Authors:  Norbert Galldiks; Marcus Unterrainer; Natalie Judov; Gabriele Stoffels; Marion Rapp; Philipp Lohmann; Franziska Vettermann; Veronika Dunkl; Bogdana Suchorska; Jörg C Tonn; Friedrich-Wilhem Kreth; Gereon R Fink; Peter Bartenstein; Karl-Josef Langen; Nathalie L Albert
Journal:  Neuro Oncol       Date:  2019-10-09       Impact factor: 12.300

7.  [18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma.

Authors:  Markus Hutterer; Martha Nowosielski; Daniel Putzer; Nathalie L Jansen; Marcel Seiz; Michael Schocke; Mark McCoy; Georg Göbel; Christian la Fougère; Irene J Virgolini; Eugen Trinka; Andreas H Jacobs; Günther Stockhammer
Journal:  Neuro Oncol       Date:  2013-01-17       Impact factor: 12.300

8.  Serial 18F-FET PET Imaging of Primarily 18F-FET-Negative Glioma: Does It Make Sense?

Authors:  Marcus Unterrainer; Florian Schweisthal; Bogdana Suchorska; Vera Wenter; Christine Schmid-Tannwald; Wolfgang P Fendler; Ulrich Schüller; Peter Bartenstein; Jörg-Christian Tonn; Nathalie L Albert
Journal:  J Nucl Med       Date:  2016-03-31       Impact factor: 10.057

Review 9.  Comparison of amino acid positron emission tomographic radiotracers for molecular imaging of primary and metastatic brain tumors.

Authors:  Csaba Juhász; Shalini Dwivedi; David O Kamson; Sharon K Michelhaugh; Sandeep Mittal
Journal:  Mol Imaging       Date:  2014       Impact factor: 4.488
  9 in total
  3 in total

1.  Comment on "Hypometabolic gliomas on FET-PET-is there an inverted U-curve for survival?"

Authors:  Norbert Galldiks; Antoine Verger; Timothée Zaragori; Marcus Unterrainer; Bogdana Suchorska; Philipp Lohmann; Jörg C Tonn; Karl-Josef Langen; Nathalie L Albert
Journal:  Neuro Oncol       Date:  2019-12-17       Impact factor: 12.300

2.  L-type amino acid transporter (LAT) 1 expression in 18F-FET-negative gliomas.

Authors:  Franziska J Vettermann; Caroline Diekmann; Lorraine Weidner; Marcus Unterrainer; Bogdana Suchorska; Viktoria Ruf; Mario Dorostkar; Vera Wenter; Jochen Herms; Jörg-Christian Tonn; Peter Bartenstein; Markus J Riemenschneider; Nathalie L Albert
Journal:  EJNMMI Res       Date:  2021-12-14       Impact factor: 3.138

3.  The Relationship Between IDH1 Mutation Status and Metabolic Imaging in Nonenhancing Supratentorial Diffuse Gliomas: A 11C-MET PET Study.

Authors:  Nijiati Kudulaiti; Huiwei Zhang; Tianming Qiu; Junfeng Lu; Abudumijiti Aibaidula; Zhengwei Zhang; Yihui Guan; Dongxiao Zhuang
Journal:  Mol Imaging       Date:  2019 Jan-Dec       Impact factor: 4.488
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.